Close Menu
Home » Malaria Parasite Re-Sequencing Uncovers Possible Drug Resistance Genes

Malaria Parasite Re-Sequencing Uncovers Possible Drug Resistance Genes

Oct 26, 2010

By Andrea Anderson

NEW YORK (GenomeWeb News) – By re-sequencing and analyzing the genome of Plasmodium vivax directly from an infected patient's blood, an international research team has identified several genes that appear to be under selection — and may contribute to drug resistance — in the malaria-causing parasite.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Unexpected Close

GenomeWeb reports that Veritas Genetics is suspending its US operations.

Sweet Assembly

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Oh, You're Aging Well

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

Science Papers Describe MicroRNA Targeting Efficiency, Approach for Single-Cell High-Throughput Chemical Screens

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

What's Popular?

In Clinical Sequencing

  1. Gene Panel Finds Pathogenic Variants Missed by Standard Tests in 5 Percent of Familial Cancer Cases

  2. Childhood Kidney Cancer Arises From Altered Normal Tissue, Sequencing Study Finds

  3. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

  4. SciLifeLab Researchers Develop Multiplexed Library Prep Method for FFPE Samples

    Premium

  5. Enpicom, Cytura Therapeutics to Develop Cancer Diagnostic

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.